Pfizer data boosts hopes children will soon be eligible for COVID-19 vaccine, and CDC expands booster program

Pfizer data boosts hopes children will soon be eligible for COVID-19 vaccine, and CDC expands booster program
·6 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

There was good news for parents Friday when Pfizer said the vaccine it developed with German partner BioNTech proved 90.7% effective in preventing symptomatic COVID-19 in children aged 5 to 11 in a clinical trial, using a 10 mg dose instead of the 30 mg given to adults.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting